(Health-NewsWire.Net, December 08, 2017 ) According to the report, North America biomarkers Industry published by the Market Data Forecast. The Industry has been expected to reach USD 16.72 billion by 2020 from USD 9.57 billion in 2015, growing at a CAGR of 11.80% during forecast period 2015-2020.
Browse Industry data tables and in-depth TOC of the North America biomarkers Industry to 2021 @ http://www.marketdataforecast.com/market-reports/north-america-biomarkers-market-193/
Biomarkers are described as the biological molecules or genes assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery & development processes and assessment of disease conditions.
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/north-america-biomarkers-market-193/request-sample
Key Points from Table of Contents
Overview o Executive Summary o Key Inferences o New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) o Industry Segmentation o By Product o By Type o By Application o By Disease Indications Geographical Analysis Pipeline Product Analysis o Strategic Analysis o PESTLE analysis o Porters Five analysis
Industry Leaders' Analysis Competitive Landscape
Growing number of cancer patients, rising adoption of advanced technologies (such as advanced high throughput technologies), increasing research to discover & develop the innovative biomarkers, and existence of huge number of pharmaceutical companies are driving the growth of biomarkers Industry in North America. In addition, growing funding from public & private organizations, presence of major Industry players, and increasing collaborations among the pharmaceutical companies are further propelling the growth of biomarkers Industry in North America. However, poor regulatory systems and reimbursement policies for the validation of biomarkers tests are restraining the growth of biomarkers Industry in North America.
North America biomarkers Industry is segmented based on the product, type, application, and disease indications. Based on product, the Industry is further sub-segmented as consumables, software, and services. Based on type, the Industry is segmented as safety biomarkers, efficacy biomarkers, and validation biomarkers. Biomarkers application is further segmented as diagnostics developments, drug discovery & developments, personalized medicine, and disease risk assessment. Based on disease indications, the Industry is segmented as cancer, cardiovascular, neurological, and immunological disorders.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/north-america-biomarkers-market-193
On the basis of geographical areas, North America biomarker Industry is segmented as U.S., and Canada.
The key players in biomarkers Industry include, Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|